TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03649841

Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“Terminated due to low accrual.”

The sponsor’s own words in the registry.

Life of this trial

2018201920202021202220232024Registered2018-08-22Started2020-06-29Primary completion2022-09-01Stopped2023-02-01Results posted2023-10-26

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
University of Washington
Sponsor type
University, hospital or other
Conditions
Castration-Sensitive Prostate Carcinoma; Metastatic Malignant Neoplasm in the Bone; Metastatic Prostate Carcinoma; Prostate Adenocarcinoma; Prostate Small Cell Neuroendocrine Carcinoma; Stage IV Prostate Cancer AJCC v8
Interventions
Antiandrogen Therapy; Abiraterone Acetate; Prednisone; Radiation Therapy
Participants
10
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.